Author： Muszkat M. Pappo O. Caraco Y. Haviv Y.S.
Publisher： Adis International
ISSN： 1173-2563
Source： Clinical Drug Investigation, Vol.19, Iss.1, 2000-01, pp. : 75-78
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Immunomodulatory treatment for myasthenia gravis
Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. :
Access to resources
Recommend
Myasthenia Gravis: Therapy Is Complex
Pharmaceutical Innovation, Vol. 11, Iss. 2, 2002-03 ,pp. :
Mouse Models of Myasthenia Gravis
Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. :
Diagnosis and Management of Autoimmune Myasthenia Gravis
Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. :
Fluoroquinolones linked with myasthenia gravis exacerbation
Reactions Weekly, Vol. 1, Iss. 1370, 2011-01 ,pp. :